Wuhan Medicine Valley Technology Development Co., Ltd.

Primary objective: To confirm the effectiveness of Xiangju Rupining Capsules in the treatment of breast hyperplasia (liver depression and phlegm stagnation syndrome), and to confirm that Xiangju Rupining Capsules can effectively increase the proportion of patients with pain relief compared with placebo. Secondary objective: To confirm the effectiveness of Xiangju Rupining Capsules in the treatment of breast hyperplasia (liver depression and phlegm stagnation syndrome), and to confirm that Xiangju Rupining Capsules can effectively increase the proportion of patients with pain relief compared with placebo. To confirm the effectiveness of Xiangju Rupining Capsules in the treatment of breast hyperplasia (liver depression and phlegm stagnation syndrome), and to confirm that Xiangju Rupining Capsules can effectively reduce breast pain and liver depression and phlegm stagnation symptoms in patients with breast hyperplasia (liver depression and phlegm stagnation syndrome) and improve their quality of life compared with placebo. To confirm the safety of Xiangju Rupining Capsules in the treatment of patients with breast hyperplasia (liver depression and phlegm stagnation syndrome).

(1) To explore the effect of Susu Children's Cough Relief Granules in shortening the course of illness and improving symptoms in treating cough caused by the common cold (cold cough) in children. (2) To observe the safety of Susu Children's Cough Relief Granules in clinical application.

A randomized, double-blind, placebo-controlled, multicenter clinical trial design was used to preliminarily evaluate the efficacy and safety of Xiangju Rupining Capsule in the treatment of fibrocystic fibrosis (liver depression and phlegm stagnation syndrome) and conduct dose exploration.